Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, that are being simultaneously presented at the American Heart Association’s 2024 Scientific Sessions.
Scientists weigh in on RFK Jr. as HHS secretary
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. The schedule at my YMCA recently changed